Teladoc Health is a publicly listed company tracked for investment-relevant business developments.
Teladoc is sold to businesses with ~100M subscribers but few actually use it; Hims & Hers' direct-to-consumer model where users choose to engage is a more valuable position than B2B distribution with low utilization.